Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

KURA Kura Oncology, Inc

交易中 07-22 15:04:43 EDT

20.74

-0.21

-1.00%

最高21.20	最低20.44	成交量30.93万
今开21.14	昨收20.95	日振幅3.63%
总市值15.80亿	流通市值10.08亿	总股本7,618万
成交额641.54万	换手率0.64%	流通股本4,862万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"KURA","market":"US","secType":"STK","nameCN":"Kura Oncology, Inc","latestPrice":20.74,"timestamp":1721675083130,"preClose":20.95,"halted":0,"volume":309270,"delay":0,"floatShares":48617405,"shares":76180620,"eps":-2.179989,"marketStatus":"交易中","marketStatusCode":2,"change":-0.21,"latestTime":"07-22 15:04:43 EDT","open":21.14,"high":21.2,"low":20.44,"amount":6415414.61418,"amplitude":0.036277,"askPrice":20.77,"askSize":101,"bidPrice":20.73,"bidSize":239,"shortable":3,"etf":0,"ttmEps":-2.179989,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1446699600000,"adjPreClose":20.95,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.95,"preClose":20.95,"latestTime":"19:53 EDT","volume":7929,"amount":166115.0424,"timestamp":1721433211436},"volumeRatio":0.588588,"impliedVol":0.559,"impliedVolPercentile":0.1952},"requestUrl":"/m/hq/s/KURA/wiki","defaultTab":"wiki","newsList":[{"id":"2452670166","title":"Kura Oncology, Inc.盘中异动 大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452670166","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452670166?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:03","pubTimestamp":1721228631,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时03分，Kura Oncology, Inc.股票出现异动，股价大幅下跌5.12%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为2.29%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Aditxt, Inc.涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2838.28%、1253.00%、269.00%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Aditxt, Inc.，振幅分别为76.39%、43.75%、38.13%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230351941f7f0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230351941f7f0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2450936341","title":"Kura Oncology, Inc.盘中异动 早盘股价大涨5.16%报21.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450936341","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450936341?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:49","pubTimestamp":1720705757,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时49分，Kura Oncology, Inc.股票出现波动，股价快速拉升5.16%。截至发稿，该股报21.38美元/股，成交量9.4458万股，换手率0.12%，振幅4.18%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214918af91de2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711214918af91de2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2444243218","title":"Kura Oncology, Inc.盘中异动 早盘股价大跌5.30%报19.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444243218","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444243218?lang=zh_cn&edition=full","pubTime":"2024-06-18 23:03","pubTimestamp":1718723034,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日23时03分，Kura Oncology, Inc.股票出现异动，股价快速跳水5.30%。截至发稿，该股报19.59美元/股，成交量16.0424万股，换手率0.21%，振幅5.90%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618230354941ef417&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618230354941ef417&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2442355254","title":"Kura Oncology, Inc.盘中异动 股价大涨5.51%报22.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442355254","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442355254?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:31","pubTimestamp":1718199091,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时31分，Kura Oncology, Inc.股票出现波动，股价急速上涨5.51%。截至发稿，该股报22.68美元/股，成交量8747股，换手率0.01%，振幅3.58%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313196813b05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221313196813b05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2442847968","title":"Kura Oncology, Inc.盘中异动 大幅下跌5.10%报20.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442847968","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442847968?lang=zh_cn&edition=full","pubTime":"2024-06-10 22:11","pubTimestamp":1718028701,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日22时11分，Kura Oncology, Inc.股票出现异动，股价急速下跌5.10%。截至发稿，该股报20.65美元/股，成交量4.7662万股，换手率0.06%，振幅3.08%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221141968130b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610221141968130b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2441783649","title":"Kura Oncology, Inc.盘中异动 临近收盘快速拉升5.00%报21.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441783649","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441783649?lang=zh_cn&edition=full","pubTime":"2024-06-06 03:56","pubTimestamp":1717617401,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日03时56分，Kura Oncology, Inc.股票出现波动，股价快速上涨5.00%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Kineta, Inc.、Vigil Neuroscience, Inc.、Fresh2 Group Limited涨幅较大，Cns Pharmaceuticals, Inc.、Virios Therapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为161.16%、70.47%、54.35%，振幅较大的相关个股有Virios Therapeutics, Inc.、Fresh2 Group Limited、Kineta, Inc.，振幅分别为70.40%、68.81%、63.28%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606035641aef3947b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606035641aef3947b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2440496179","title":"Kura Oncology, Inc.盘中异动 早盘大幅拉升5.07%报21.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440496179","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440496179?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:03","pubTimestamp":1717423392,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时03分，Kura Oncology, Inc.股票出现波动，股价快速拉升5.07%。截至发稿，该股报21.66美元/股，成交量3.42万股，换手率0.04%，振幅4.85%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603220313af8ba9e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603220313af8ba9e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2435251608","title":"Kura Oncology, Inc.盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435251608","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435251608?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:34","pubTimestamp":1715693680,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时34分，Kura Oncology, Inc.股票出现波动，股价快速拉升5.24%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Nutriband Inc C/Wts 、Allogene Therapeutics, Inc.、Generation Bio Co.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为39.16%、8.48%、7.49%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Imunon, Inc.、Absci Corporation，振幅分别为21.54%、17.57%、16.99%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421344079279e85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051421344079279e85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2434987676","title":"Kura Oncology, Inc.2024财年第一财季实现净利润-49.53百万美元，同比减少45.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434987676","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434987676?lang=zh_cn&edition=full","pubTime":"2024-05-12 00:19","pubTimestamp":1715444354,"startTime":"0","endTime":"0","summary":"3月31日，Kura Oncology, Inc.公布财报，公告显示公司2024财年第一财季净利润为-49.53百万美元，同比减少45.38%；其中营业收入为0.00美元，每股基本收益为-0.59美元。从资产负债表来看，Kura Oncology, Inc.总负债48.82百万美元，其中短期债务1.36百万美元，资产负债比为0.12，流动比率为0.17。机构评级：截至2024年3月31日，当前有12家机构对Kura Oncology, Inc.目标价做出预测，其中目标均价为30.25美元，其中最低目标价为21.00美元，最高目标价为37.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120019188af92903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405120019188af92903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA"],"gpt_icon":0},{"id":"2432966401","title":"库拉肿瘤公司（Kura Oncology Inc）公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432966401","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432966401?lang=zh_cn&edition=full","pubTime":"2024-05-03 07:03","pubTimestamp":1714690995,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc   报告了截至3月底的季度调整后每股亏损59美分，低于去年同期的每股-50美分。12位分析师对该季度的平均预期是每股亏损55美分。华尔街预期为每股-68美分至-44美分。* Kura Oncology Inc 报告的本季度每股收益为亏损 59 美分。* 该公司当季亏损 4953 万美元。* Kura Oncology Inc本季度股价下跌了4.9%，今年迄今为止上涨了41.0%。5月2日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 2%。华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KURA","BK4505"],"gpt_icon":0},{"id":"2432635498","title":"Kura Oncology, Inc.盘中异动 急速上涨5.05%报20.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635498","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432635498?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:01","pubTimestamp":1714590113,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时01分，Kura Oncology, Inc.股票出现异动，股价快速拉升5.05%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为2.39%。其相关个股中，Cytomx Therapeutics, Inc.、Bioatla, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1415.30%、1222.24%、268.04%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203015487e853be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203015487e853be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2429115524","title":"Kura Oncology, Inc.盘中异动 大幅上涨5.03%报19.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429115524","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429115524?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:19","pubTimestamp":1713881996,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时19分，Kura Oncology, Inc.股票出现波动，股价急速上涨5.03%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。该信息摘要如下：HC Wainwright & Co.：重申Kura Oncology评级，由买入调整至买入评级, 目标价32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232219567922b2e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232219567922b2e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","KURA","BK4139"],"gpt_icon":0},{"id":"2429977911","title":"HC Wainwright & Co.：重申Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价32.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429977911","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429977911?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:55","pubTimestamp":1713808510,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Kura Oncology(KURA.US)评级，由买入调整至买入评级, 目标价32.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301551187a24ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301551187a24ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA"],"gpt_icon":0},{"id":"2429597668","title":"Kura Oncology, Inc.盘中异动 股价大涨5.02%报18.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429597668","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429597668?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:57","pubTimestamp":1713801420,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时57分，Kura Oncology, Inc.股票出现波动，股价大幅上涨5.02%。截至发稿，该股报18.41美元/股，成交量31.3732万股，换手率0.41%，振幅2.68%。Kura Oncology, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222357007a549cb1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222357007a549cb1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2427759055","title":"Kura Oncology, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427759055","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427759055?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:41","pubTimestamp":1712947261,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时41分，Kura Oncology, Inc.股票出现波动，股价快速跳水5.14%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.56%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3675.78%、1450.50%、102.76%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为93.97%、73.57%、58.59%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241017920408b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130241017920408b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4505","BK4139"],"gpt_icon":0},{"id":"2424202640","title":"Kura Oncology, Inc.盘中异动 急速下挫5.04%报20.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424202640","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424202640?lang=zh_cn&edition=full","pubTime":"2024-04-03 01:40","pubTimestamp":1712079650,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日01时40分，Kura Oncology, Inc.股票出现异动，股价大幅下挫5.04%。截至发稿，该股报20.72美元/股，成交量22.489万股，换手率0.30%，振幅2.15%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403014050791e8260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403014050791e8260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KURA","BK4139","BK4505"],"gpt_icon":0},{"id":"2420477414","title":"Kura Oncology, Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420477414","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420477414?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:52","pubTimestamp":1710769972,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时52分，Kura Oncology, Inc.股票出现波动，股价快速下跌5.06%。Kura Oncology, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Immuneering Corporation、Celularity Inc C/Wts 16/07/2026 涨幅较大，Zyversa Therapeutics, Inc.、Scisparc Ltd.、Tc Biopharm  Plc较为活跃，换手率分别为64.97%、14.39%、12.39%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Immuneering Corporation、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为38.07%、29.27%、28.71%。Kura Oncology, Inc.公司简介：Kura Oncology Inc 是一家临床阶段的生物制药公司，致力于发现和开发用于治疗实体肿瘤和血癌的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821525287e79c5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821525287e79c5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","KURA"],"gpt_icon":0},{"id":"2414374963","title":"库拉肿瘤公司（Kura Oncology Inc）公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2414374963","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2414374963?lang=zh_cn&edition=full","pubTime":"2024-02-28 07:45","pubTimestamp":1709077506,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc   报告了截至12月底的季度调整后每股亏损55美分，低于去年同期的每股收益-49美分。华尔街预期为每股-68美分至-49美分。* Kura Oncology Inc 报告的本季度每股收益为亏损 55 美分。* 该公司当季亏损 4279 万美元。* 本季度，Kura Oncology Inc 的股价上涨了 44.2%。2月27日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测上升了约 1%。华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元。本摘要由 LSEG 2 月 27 日 11:44 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KURA"],"gpt_icon":0},{"id":"2413238719","title":"Kura Oncology Inc   预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413238719","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2413238719?lang=zh_cn&edition=full","pubTime":"2024-02-24 05:05","pubTimestamp":1708722339,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc    将于2月27日公布截至2023年12月31日的财报，预计季度收入将保持不变。*    * LSEG的分析师平均预计Kura Oncology Inc每股亏损55美分。* 华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元，高于其最新收盘价 19.59 美元。2月23日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA"],"gpt_icon":0},{"id":"2412166707","title":"Kura Oncology Inc   预计每股亏损 55 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412166707","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412166707?lang=zh_cn&edition=full","pubTime":"2024-02-20 06:21","pubTimestamp":1708381298,"startTime":"0","endTime":"0","summary":"   * Kura Oncology Inc    将于2月21日公布截至2023年12月31日的财报，预计季度营收将没有变化()    *    * LSEG 的分析师平均预计 Kura Oncology Inc 每股亏损 55 美分。* 华尔街对 Kura Oncology Inc 的 12 个月目标价中位数为 32.00 美元，高于其上次收盘价 20.62 美元。2月19日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kuraoncology.com","stockEarnings":[{"period":"1week","weight":-0.0643},{"period":"1month","weight":0.0597},{"period":"3month","weight":0.1951},{"period":"6month","weight":0.4261},{"period":"1year","weight":0.9028},{"period":"ytd","weight":0.4569}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Kura Oncology, Inc.是一家临床阶段的生物制药公司发现和开发个性化的治疗实体肿瘤和血癌的治疗。该公司专注于开发小分子产品的候选人，靶细胞信号转导途径，是重要的推动某些癌症的进展。该公司的目标是使用分子诊断，以确定癌症谁可能受益于该公司有针对性的产品候选人。 该公司成立于2007年11月特拉华州。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037302},{"month":2,"riseRate":0.555556,"avgChangeRate":0.03336},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.017219},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.03462},{"month":5,"riseRate":0.555556,"avgChangeRate":0.031537},{"month":6,"riseRate":0.444444,"avgChangeRate":0.040223},{"month":7,"riseRate":0.444444,"avgChangeRate":0.036882},{"month":8,"riseRate":0.375,"avgChangeRate":0.043624},{"month":9,"riseRate":0.5,"avgChangeRate":0.145277},{"month":10,"riseRate":0.25,"avgChangeRate":-0.098431},{"month":11,"riseRate":0.875,"avgChangeRate":0.084928},{"month":12,"riseRate":0.555556,"avgChangeRate":0.043952}],"exchange":"NASDAQ","name":"Kura Oncology, Inc","nameEN":"Kura Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Kura Oncology, Inc,KURA,Kura Oncology, Inc股票,Kura Oncology, Inc股票老虎,Kura Oncology, Inc股票老虎国际,Kura Oncology, Inc行情,Kura Oncology, Inc股票行情,Kura Oncology, Inc股价,Kura Oncology, Inc股市,Kura Oncology, Inc股票价格,Kura Oncology, Inc股票交易,Kura Oncology, Inc股票购买,Kura Oncology, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kura Oncology, Inc(KURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Kura Oncology, Inc(KURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}